What is KLOW?

KLOW is an advanced research peptide formulation that combines four synergistic compounds: TB-500 (10 mg), BPC-157 (10 mg), GHK-Cu (50 mg), and KPV (10 mg). This blend is supplied in a single 80 mg vial of lyophilised powder and is designed for in vitro research into cellular modulation, inflammatory pathways, and peptide-based signalling mechanisms. Every batch is manufactured to research-grade standards with ≥98% HPLC-verified purity.

Research Applications

• Analysis of multi-peptide receptor interactions
• Investigations into cellular signalling pathways
• Studies involving copper peptide (GHK-Cu) mechanisms
• Exploration of KPV in inflammation modulation research

Key Features

• 4-in-1 research peptide formulation
• Total content: 80 mg lyophilised powder
• Includes TB-500, BPC-157, GHK-Cu, and KPV
• ≥98% purity (HPLC verified)
• Batch-specific Certificate of Analysis (COA) available

Specifications

Reconstitution & Handling

• Reconstitute using bacteriostatic water or a suitable research solvent
• Gently swirl until dissolved; avoid excessive agitation
• Aliquot if storing reconstituted peptide to avoid freeze–thaw degradation

Quality & Testing

All KLOW peptide vials undergo high-performance liquid chromatography (HPLC) testing and mass spectrometry analysis to confirm purity and identity. COAs are batch-specific and available upon request.

Important Notice

For laboratory research use only. Not for human consumption, medical use, or diagnostic procedures.